Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model
-
Published:2022-06-04
Issue:5
Volume:25
Page:862-878
-
ISSN:1436-3291
-
Container-title:Gastric Cancer
-
language:en
-
Short-container-title:Gastric Cancer
Author:
Yamaguchi Kyoko, Yoshihiro Tomoyasu, Ariyama HiroshiORCID, Ito Mamoru, Nakano Michitaka, Semba Yuichiro, Nogami Jumpei, Tsuchihashi Kenji, Yamauchi Takuji, Ueno Shohei, Isobe Taichi, Shindo Koji, Moriyama Taiki, Ohuchida Kenoki, Nakamura Masafumi, Nagao Yoshihiro, Ikeda Tetsuo, Hashizume Makoto, Konomi Hiroyuki, Torisu Takehiro, Kitazono Takanari, Kanayama Tomohiro, Tomita Hiroyuki, Oda Yoshinao, Kusaba Hitoshi, Maeda Takahiro, Akashi Koichi, Baba Eishi
Funder
Japan Society for the Promotion of Science Japan Agency for Medical Research and Development Shinnihon Foundation of Advanced Medical Treatment Research
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Gastroenterology,Oncology,General Medicine
Reference70 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. 2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. 3. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML, Ajani JA, V325 Study Group. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol. 2006;24(31):4991–7. 4. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK, ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–97. 5. Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Chen LT. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10111):2461–71.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|